Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$76.01 - $86.7 $34,204 - $39,015
450 New
450 $34,000
Q2 2022

Jul 14, 2022

SELL
$57.72 - $65.01 $1,500 - $1,690
-26 Closed
0 $0
Q1 2022

Apr 28, 2022

BUY
$57.92 - $72.58 $1,505 - $1,887
26 New
26 $2,000
Q1 2019

May 10, 2019

SELL
$62.53 - $70.05 $70,658 - $79,156
-1,130 Closed
0 $0
Q3 2018

Oct 12, 2018

BUY
$71.28 - $78.92 $57,024 - $63,136
800 Added 242.42%
1,130 $87,000
Q2 2018

Aug 15, 2018

SELL
$64.88 - $75.68 $11,029 - $12,865
-170 Reduced 34.0%
330 $23,000
Q1 2018

May 08, 2018

BUY
$72.84 - $88.8 $5,098 - $6,216
70 Added 16.28%
500 $38,000
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $14,230 - $16,704
200 Added 86.96%
430 $31,000
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $7,571 - $8,974
105 Added 84.0%
230 $19,000
Q2 2017

Aug 10, 2017

BUY
N/A
125
125 $9,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Pittenger & Anderson Inc Portfolio

Follow Pittenger & Anderson Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pittenger & Anderson Inc with notifications on news.